Genetic data from 139,416 human embryos were used to characterize chromosomal abnormalities, called aneuploidies, that underlie many cases of pregnancy loss. This approach revealed a relationship ...
Welcome to Yara's fourth quarter results presentation. Today's presentation will be held by our CEO, Svein Tore Holsether; and our CFO, Magnus Krogh Ankarstrand. After the presentation, at 1:00 p.m.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results